Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-087579
Filing Date
2026-03-03
Accepted
2026-03-03 13:33:27
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4620
  Complete submission text file 0001193125-26-087579.txt   6057
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 41 SEYON STREET, SUITE 100 WALTHAM MA 02453
Business Address
Garland Jason K (Reporting) CIK: 0001754555 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 26712477